Brand-name drug
Xeljanz price, strengths & recalls
Brand of tofacitinib (generic)
Pharmacies pay $2,213.15 for 30 tablets of Xeljanz 5 mg tablet this week, and from $2,213.15 to $6,236.93 across its 3 priced strengths and forms. The generic, tofacitinib, costs pharmacies from $16.86.
Medicare price 2028Brand- Fair cash price
- $2,555.62
- Strengths
- 3
- Makers
- 1
- Updated
- Nov 11
Xeljanz price by strength
What pharmacies pay for each strength and form this week (Nov 11, 2026), for 30 tablets. Choose one for its fair price, 52-week chart and makers.
| Strength and form | Per unit | Pharmacies pay |
|---|---|---|
| 11 mg (24 hr) extended-release tablet Brand | $207.90 | $6,236.93 / 30 tablets |
| 5 mg tablet Brand | $73.77 | $2,213.15 / 30 tablets |
| 10 mg tablet Brand | $103.94 | $3,118.15 / 30 tablets |
The lowest cost per tablet is 5 mg tablet at $73.77. Strengths aren't interchangeable - ask your pharmacist or prescriber before changing.
Xeljanz vs generic tofacitinib
Generics have the same active ingredient, strength and form, and FDA requires them to work the same way. What pharmacies pay for each, same quantity:
| Strength | Brand | Generic | Brand costs |
|---|---|---|---|
| 11 mg (24 hr) extended-release tablet | $6,236.93 | $62.63 | 99.6x |
| 5 mg tablet | $2,213.15 | $16.86 | 131.3x |
Medicare negotiated price
Xeljanz was selected for Medicare price negotiation. Its negotiated price takes effect on January 1, 2028; the price itself is published by the end of November 2026.
What this means for patients
- The negotiated price is what Medicare Part D plans pay for the drug - not your price at the counter.
- What you pay depends on your plan's copay or coinsurance and where you are in the year. Coinsurance (a percentage) falls with the price; a flat copay may not change at all.
- Out-of-pocket costs for Part D drugs are capped each year ($2,100 in 2026), whatever the drug.
- If you don't have Medicare, the negotiated price doesn't apply to you - check the fair cash price above instead.
Supply status: shortages & recalls
What people paid for Xeljanz
Bought it recently? Share the price, the pharmacy and how you paid - it's the most useful thing the next person can read.
Approval, patents & generics
- Application
- NDA203214 · Pf Prism Cv
- First approved
- November 6, 2012 (14 years ago)
- Latest approved change
- September 16, 2026
- Approved label
- PDF, Sep 22, 2026
- Generic makers
- 21 approved generic applications on the market
- Last patent listed
- June 8, 2026 (expired)
- Exclusivity ends
- August 21, 2028
Xeljanz questions
How much does xeljanz cost without insurance?
Pharmacies pay about $2,213.15 for 30 tablets of xeljanz 5 mg tablet ($73.77 per tablet). A fair cash price - that cost plus a 15% margin and a typical dispensing fee - is about $2,555.62. If you're quoted much more, check your quote and ask for the pharmacy's cash price.
Is there a generic for Xeljanz?
Yes: tofacitinib. Pharmacies pay from $16.86 for it. Compare tofacitinib prices.
Is xeljanz in shortage?
No shortage is reported for xeljanz right now. We check the national shortage list every day.
Has xeljanz been recalled?
No recalls are on record for xeljanz.
Does Medicare have a negotiated price for Xeljanz?
Yes - Xeljanz was selected and its negotiated price starts January 1, 2028.
Talk about xeljanz
No comments yet. Questions, tips, what worked for you - start the conversation.